MHK's second-quarter 2025 results reflect gains from cost control and product mix, offset by margin pressure and weak volumes.

MHK's second-quarter 2025 results reflect gains from cost control and product mix, offset by margin pressure and weak volumes.

LVS posts strong second-quarter results driven by strength in Singapore, improved services and Macao investments.

WAB's second-quarter 2025 earnings are aided by higher sales, operating margin expansion and benefits from share repurchases.

AngioDynamics beats fourth-quarter fiscal 2025 estimates with strong Med Tech growth amid margin declines and a wider fiscal 2026 loss outlook.

AngioDynamics beats fourth-quarter fiscal 2025 estimates with strong Med Tech growth amid margin declines and a wider fiscal 2026 loss outlook.

DPZ stock jumps after second-quarter revenues beat despite an earnings miss, boosted by store growth and aggregator expansion.

DPZ stock jumps after second-quarter revenues beat despite an earnings miss, boosted by store growth and aggregator expansion.

VMI's second-quarter profit and revenues beat estimates. Full-year EPS outlook is up, factoring in the impacts of the realignment actions.

BMI's Q2 results may reflect strong utility demand and smart tech growth, despite tougher comps and macro headwinds.